Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Insights on the Beneficial Effects of the Probiotic Kefir on Vascular Dysfunction in Cardiovascular and Neurodegenerative Diseases
Elisardo C. Vasquez, Rafaela Aires, Alyne Mendonça Marques Ton, et al.
Current Pharmaceutical Design (2020) Vol. 26, Iss. 30, pp. 3700-3710
Closed Access | Times Cited: 20

Showing 20 citing articles:

Fungi as a Source of Edible Proteins and Animal Feed
Amro Abd Al Fattah Amara, Nawal Abd El‐Baky
Journal of Fungi (2023) Vol. 9, Iss. 1, pp. 73-73
Open Access | Times Cited: 71
The future of functional food: Emerging technologies application on prebiotics, probiotics and postbiotics
Celso F. Balthazar, Jonas F. Guimarães, Nathália M. Coutinho, et al.
Comprehensive Reviews in Food Science and Food Safety (2022) Vol. 21, Iss. 3, pp. 2560-2586
Closed Access | Times Cited: 63
Gut Microbiome and Neurodevelopmental Disorders: A Link Yet to Be Disclosed
Zoi Iliodromiti, Anastasia-Rafaella Triantafyllou, Marina Tsaousi, et al.
Microorganisms (2023) Vol. 11, Iss. 2, pp. 487-487
Open Access | Times Cited: 31
Stroke and Vascular Cognitive Impairment: The Role of Intestinal Microbiota Metabolite TMAO
Ruxin Tu, Jian Xia
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 1, pp. 102-121
Closed Access | Times Cited: 22
The Role of the Microbiota-Gut-Brain Axis in the Health and Illness Condition: A Focus on Alzheimer’s Disease
Mónica De la Fuente
Journal of Alzheimer s Disease (2021) Vol. 81, Iss. 4, pp. 1345-1360
Closed Access | Times Cited: 33
Kefir metabolites in a fly model for Alzheimer’s disease
Letícia Leandro Batista, Serena Mares Malta, Heitor Cappato Guerra Silva, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 32
Nutraceuticals-based therapeutic approach: recent advances to combat pathogenesis of Alzheimer’s disease
Marjan Talebi, Eleni Kakouri, Mohsen Talebi, et al.
Expert Review of Neurotherapeutics (2021) Vol. 21, Iss. 6, pp. 625-642
Closed Access | Times Cited: 31
UPLC-QTOF-MS/MS and GC-MS Characterization of Phytochemicals in Vegetable Juice Fermented Using Lactic Acid Bacteria from Kimchi and Their Antioxidant Potential
Moeun Lee, Jung Hee Song, Eun Ji Choi, et al.
Antioxidants (2021) Vol. 10, Iss. 11, pp. 1761-1761
Open Access | Times Cited: 30
The Emerging Scenario of the Gut–Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases
Thiago de Melo Costa Pereira, Larissa Zambom Côco, Alyne M. M. Ton, et al.
Antioxidants (2021) Vol. 10, Iss. 11, pp. 1845-1845
Open Access | Times Cited: 28
The Gut Microbiota-Brain Axis: A New Frontier on Neuropsychiatric Disorders
Sarha A. L. Queiroz, Alyne Mendonça Marques Ton, Thiago de Melo Costa Pereira, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 21
Therapeutic approaches of nutraceuticals in the prevention of Alzheimer's disease
Surya Nath Pandey, Gurfateh Singh, Bhupesh Chander Semwal, et al.
Journal of Food Biochemistry (2022) Vol. 46, Iss. 12
Open Access | Times Cited: 15
Probiotic Supplements: Their Strategies in the Therapeutic and Prophylactic of Human Life-Threatening Diseases
Mahmoud Youssef, Hanaa Y. Ahmed, Abel Wend‐Soo Zongo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11290-11290
Open Access | Times Cited: 18
Mechanisms by which microbiome-derived metabolites exert their impacts on neurodegeneration
Lara Kern, Ignacio Mastandrea, A. M. Melekhova, et al.
Cell chemical biology (2024)
Closed Access | Times Cited: 2
Physiopathological mechanisms involved in the development of hypertension associated with gut dysbiosis and the effect of nutritional/pharmacological interventions
Virna Margarita Martín Giménez, Natalia L. Rukavina Mikusic, Hyun Jin Lee, et al.
Biochemical Pharmacology (2022) Vol. 204, pp. 115213-115213
Closed Access | Times Cited: 7
Use of kefir peptide (Kef-1) as an emerging approach for the treatment of oxidative stress and inflammation in 2K1C mice
Rafaela Aires, Fernanda Gobbi Amorim, Larissa Zambom Côco, et al.
Food & Function (2022) Vol. 13, Iss. 4, pp. 1965-1974
Closed Access | Times Cited: 5
Protective effects of kefir in the angiotensin II-dependent hypertension
Brenna Lepaus Monteiro, Ananda T. Dias, Sthephany C. Wanderkoke, et al.
Journal of Functional Foods (2020) Vol. 75, pp. 104260-104260
Open Access | Times Cited: 7
Brazilian kefir fraction mitigates the Alzheimer-like phenotype in Drosophila melanogaster with β-amyloid overexpression model
Serena Mares Malta, Tamíris Sabrina Rodrigues, Matheus Henrique Silva, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
New and developing pharmacotherapies for hypertension
Christián Höcht, Miguel Allo, Ariel H. Polizio, et al.
Expert Review of Cardiovascular Therapy (2022) Vol. 20, Iss. 8, pp. 647-666
Closed Access | Times Cited: 2
New Therapies for Endothelial Dysfunction: From Basic to Applied Research
Leonardo dos Santos
Current Pharmaceutical Design (2020) Vol. 26, Iss. 30, pp. 3631-3632
Closed Access
Kefir como probiótico e fonte de metabólitos: um estudo em Drosophila melanogaster modelo da Doença de Alzheimer
Letícia Leandro Batista
(2020)
Open Access
Page 1

Scroll to top